Home > Pulmonology > ERS 2020 > Lung Cancer Detection > Lung cancer screening: Most patients not eligible 1-2 years prior to diagnosis

Lung cancer screening: Most patients not eligible 1-2 years prior to diagnosis

Presented By
Dr Kiran Desai, Barking, Havering and Redbridge University Hospitals, UK
Conference
ERS 2020
An analysis of lung cancer patients in a district hospital showed that only a third of all patients would have been eligible for lung cancer screening. Additional tools are urgently needed to stratify risk and facilitate an earlier diagnosis in lung cancer patients [1]. In Europe, lung cancer ranks third among the most common cancers. “As you all know, we found a lot of evidence for using low-dose computed tomography (LDCT) to reduce lung cancer mortality in the last decade,” explained Dr Kiran Desai (Barking, Havering and Redbridge University Hospitals, UK). The National Lung Screening Trial (NLST), the Dutch NELSON, and the UK Lung Cancer Screening (UKLS) trials have all provided strong evidence for its use in reducing lung cancer mortality [2-4]. To understand the service implications for a district general hospital, Dr Desai and his team evaluated the proportion of his patients that would have been eligible for screening 1 and 2 years ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on